AFP and hepatocellular carcinoma: Moreover, the results showed that the enrichment of hepatogenic fraction of plasma EVs for HCC patients was significantly correlated with clinically accepted biomarker AFP concentration (ng/ml, P-value = 0.038, R = 0.25, Pearson correlation analysis).